Atlas Trials

Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM)

Clinical trial NCT01146262 · UNKNOWN

Trial details

NCT number
NCT01146262
Sponsor
Nantes University Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous Leukemia
Start date
2009-11-01
Primary completion
2017-04-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.